The DOI matches its Crossref record.
Tumour progression and survival in patients with T1G3 bladder tumours: 15‐year outcome
Abstract
Objective: To evaluate tumour progression and survival of patients with T1G3 bladder tumours who were followed for 15 years. Patients and methods: A subset of 48 patients with T1G3 bladder tumours was entered into a randomized trial of transurethral resection (TUR) or TUR plus bacille Calmette‐Guèrin (BCG) therapy and followed for a minimum of 15 years. Thirty‐nine (81%) patients received one or more courses of BCG. The endpoints of the study were stage progression (defined as muscle invasion or metastasis) and disease‐specific survival. Results: Of the 48 patients, 25 (52%) progressed and 15 (31%) died from the disease; 33 patients (69%) survived, including 24 (50%) with an intact bladder. The median progression‐free survival time was 151 months. Tumour progression occurred in 35% of the patients within the first 5 years, in 16% after 5–10 years and in 12% of those followed for 10–15 years. Deaths from cancer occurred in 25% of the patients in the first 5 years and in 10% of patients at risk from 5 to 15 years. Conclusions: Patients with T1G3 bladder tumours who are treated conservatively are at life‐long risk of having a muscle‐invasive tumour and dying from bladder cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oosterlinck, W., Lobel, B., Jakse, G., Malmström, P.-U., Stöckle, M., & Sternberg, C. (2002) · European Urology · doi:10.1016/s0302-2838(01)00026-4 · Cited by 464
Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J., Bermudes, D., Brecher, S. M., Margitich, D., Turnier, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315497 · Cited by 355
Ploussard, G., Daneshmand, S., Efstathiou, J. A., Herr, H. W., James, N. D., Rödel, C. M., Shariat, S. F., Shipley, W. U., Sternberg, C. N., Thalmann, G. N., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.02.038 · Cited by 355
Self-citationRecurrence of high‐risk bladder cancer: A population‐based analysis
Chamie, K., Litwin, M. S., Bassett, J. C., Daskivich, T. J., Lai, J., Hanley, J. M., Konety, B. R., Saigal, C. S., & the Urologic Diseases in America Project (2013) · Cancer · doi:10.1002/cncr.28147 · Cited by 352
Lee, J.-S., Leem, S.-H., Lee, S.-Y., Kim, S.-C., Park, E.-S., Kim, S.-B., Kim, S.-K., Kim, Y.-J., Kim, W.-J., & Chu, I.-S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0977 · Cited by 342
Metadata
- Authors
- HERR, H. W.
- Venue
- British Journal of Urology
- Publisher
- Wiley
- Published
- 1997-11
- Volume
- 80
- Issue
- 5
- Pages
- 762-765
- ISSN
- 0007-1331 (ISSN-L)
- OpenAlex
- W2081194991
- Cited by
- 171
- References
- 0
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumour progression and survival in patients with T1G3 bladder tumours: 15‐year outcome. https://app.cochat.ai/papers/10.1046/j.1464-410x.1997.00431.x
- The paper
- HERR, H. W. (1997). Tumour progression and survival in patients with T1G3 bladder tumours: 15‐year outcome. British Journal of Urology. https://doi.org/10.1046/j.1464-410x.1997.00431.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.